These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 17533009)

  • 1. The many effects of complement C3- and C5-binding proteins in renal injury.
    Puri TS; Quigg RJ
    Semin Nephrol; 2007 May; 27(3):321-37. PubMed ID: 17533009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of the fifth component of complement, and its relation to metabolism of the third component, in patients with complement activation.
    Sissons JG; Liebowitch J; Amos N; Peters DK
    J Clin Invest; 1977 Apr; 59(4):704-15. PubMed ID: 845257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of complement inactivation by glycoprotein C of herpes simplex virus.
    Kostavasili I; Sahu A; Friedman HM; Eisenberg RJ; Cohen GH; Lambris JD
    J Immunol; 1997 Feb; 158(4):1763-71. PubMed ID: 9029114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crry deficiency in complement sufficient mice: C3 consumption occurs without associated renal injury.
    Ruseva MM; Hughes TR; Donev RM; Sivasankar B; Pickering MC; Wu X; Harris CL; Morgan BP
    Mol Immunol; 2009 Feb; 46(5):803-11. PubMed ID: 18947875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Structure and function of receptors for C3 cleavage fragments].
    Fischer E; Couturier C; Weiss L; Kazatchkine MD
    Nephrologie; 1991; 12(4):169-78. PubMed ID: 1745334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active sites in complement components C5 and C3 identified by proximity to indels in the C3/4/5 protein family.
    Low PJ; Ai R; Ogata RT
    J Immunol; 1999 Jun; 162(11):6580-8. PubMed ID: 10352274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement components and receptors: deficiencies and disease associations.
    Bartholomew WR; Shanahan TC
    Immunol Ser; 1990; 52():33-51. PubMed ID: 2091785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unrestricted C3 activation occurs in Crry-deficient kidneys and rapidly leads to chronic renal failure.
    Bao L; Wang Y; Chang A; Minto AW; Zhou J; Kang H; Haas M; Quigg RJ
    J Am Soc Nephrol; 2007 Mar; 18(3):811-22. PubMed ID: 17229915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of complement fragment C5a in milk is variable among cows.
    Rainard P; Poutrel B
    J Dairy Sci; 2000 May; 83(5):945-51. PubMed ID: 10821569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement component C2, inhibiting a latent serine protease in the classical pathway of complement activation.
    Halili MA; Ruiz-Gómez G; Le GT; Abbenante G; Fairlie DP
    Biochemistry; 2009 Sep; 48(35):8466-72. PubMed ID: 19642650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse Crry/p65 is a regulator of the alternative pathway of complement activation.
    Foley S; Li B; Dehoff M; Molina H; Holers VM
    Eur J Immunol; 1993 Jun; 23(6):1381-4. PubMed ID: 8500531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predominant role for C5b-9 in renal ischemia/reperfusion injury.
    Zhou W; Farrar CA; Abe K; Pratt JR; Marsh JE; Wang Y; Stahl GL; Sacks SH
    J Clin Invest; 2000 May; 105(10):1363-71. PubMed ID: 10811844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C3, C5, and factor B bind to chitosan without complement activation.
    Marchand C; Bachand J; Périnêt J; Baraghis E; Lamarre M; Rivard GE; De Crescenzo G; Hoemann CD
    J Biomed Mater Res A; 2010 Jun; 93(4):1429-41. PubMed ID: 19927329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C5 inhibition prevents renal failure in a mouse model of lethal C3 glomerulopathy.
    Williams AL; Gullipalli D; Ueda Y; Sato S; Zhou L; Miwa T; Tung KS; Song WC
    Kidney Int; 2017 Jun; 91(6):1386-1397. PubMed ID: 28139294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural insights into the central complement component C3.
    Janssen BJ; Gros P
    Mol Immunol; 2007 Jan; 44(1-3):3-10. PubMed ID: 16875735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue-specific deletion of Crry from mouse proximal tubular epithelial cells increases susceptibility to renal ischemia-reperfusion injury.
    Miao J; Lesher AM; Miwa T; Sato S; Gullipalli D; Song WC
    Kidney Int; 2014 Oct; 86(4):726-37. PubMed ID: 24850152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in C3 activation and binding caused by phosphorylation by a casein kinase released from activated human platelets.
    Ekdahl KN; Nilsson B
    J Immunol; 1999 Jun; 162(12):7426-33. PubMed ID: 10358196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of complement in the immune response.
    Feldbush TL; Hobbs MV; Severson CD; Ballas ZK; Weiler JM
    Fed Proc; 1984 Jul; 43(10):2548-52. PubMed ID: 6610570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DAF/Crry double deficiency in mice exacerbates nephrotoxic serum-induced proteinuria despite markedly reduced systemic complement activity.
    Miwa T; Zhou L; Tudoran R; Lambris JD; Madaio MP; Nangaku M; Molina H; Song WC
    Mol Immunol; 2007 Jan; 44(1-3):139-46. PubMed ID: 16887189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal C3 complement component: feed forward to diabetic kidney disease.
    Kelly KJ; Liu Y; Zhang J; Dominguez JH
    Am J Nephrol; 2015; 41(1):48-56. PubMed ID: 25662584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.